Company / SG&A per Share
Crinetics Pharmaceuticals, Inc. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$2.00
FY2025
5-year range
$0.52 / $2.00
FY2021-FY2025
Trend
+86.5%
vs FY2024
Sector context
#80 of 210
Health Care
What the data says
At $2.00, Crinetics Pharmaceuticals, Inc.'s sg&a per share ranks #131 of 210 in the Health Care sector. SG&A per Share has increased for 5 consecutive years, from $0.27 in FY2020 to $2.00 in FY2025.
Based on SEC 10-K filings.
2.00 in FY2025 with a 5-year CAGR of +48.8%.
Increased from $1.00 to $2.00 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +36.5%
- 5-Year CAGR
- +48.8%
- 10-Year CAGR
- -
Sector benchmark
#131 of 210 in Health CareTop 62% of 210This company $2.00 Sector average $40.75
▼
-95.1% below sector average
Key checks
Key Insights
- Crinetics Pharmaceuticals, Inc.'s sg&a per share has grown for 5 consecutive years.
- In FY2025, sg&a per share increased 86.5% year-over-year.
- Ranks #80 out of 210 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.00 | +86.5% |
| FY2024 | $1.07 | +7.3% |
| FY2023 | $1.00 | +27.1% |
| FY2022 | $0.79 | +52.7% |
| FY2021 | $0.52 | +87.7% |
| FY2020 | $0.27 | -99.7% |
| FY2019 | $80.59 | +8045.8% |
| FY2018 | $0.99 | -30.0% |
| FY2017 | $1.41 | -6.7% |
| FY2016 | $1.52 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026